Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostate cancer and PARP inhibitors: progress and challenges.
Teyssonneau D, Margot H, Cabart M, Anonnay M, Sargos P, Vuong NS, Soubeyran I, Sevenet N, Roubaud G. Teyssonneau D, et al. Among authors: vuong ns. J Hematol Oncol. 2021 Mar 29;14(1):51. doi: 10.1186/s13045-021-01061-x. J Hematol Oncol. 2021. PMID: 33781305 Free PMC article. Review.
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes.
Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M, Patard JJ, Méjean A, Bensalah K; members of the Kidney Cancer group of the CCAFU. Bigot P, et al. Among authors: vuong ns. Urol Oncol. 2017 Jan;35(1):35.e15-35.e19. doi: 10.1016/j.urolonc.2016.08.012. Epub 2016 Sep 28. Urol Oncol. 2017. PMID: 27692834 Free PMC article.
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X, Doerfler A, Descazeaud A, Koutlidis N, Schneider A, Sebe P, Ingels A, Azzouzi AR, Soulié M, Méjean A, Bensalah K, Patard JJ; members of the Kidney Cancer group of the CCAFU. Bigot P, et al. Among authors: vuong ns. World J Urol. 2016 Mar;34(3):347-52. doi: 10.1007/s00345-015-1634-0. Epub 2015 Jul 7. World J Urol. 2016. PMID: 26149352 Free PMC article.
Le sous-type histologique des carcinomes tubulo-papillaires ne modifie pas les résultats oncologiques après néphrectomie partielle.
Bigot P, Bernhard J, Verhoest G, Flammand V, Gill I, Vuong N, Reix B, Suer E, Gökce I, Beauval J, Nouhaud F, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet J, Ploussard G, Roupret M, Léon P, El Bakri A, Larré S, Tillou X, Ingels A, Doerfler A. Bigot P, et al. Prog Urol. 2015 Nov;25(13):799. doi: 10.1016/j.purol.2015.08.167. Prog Urol. 2015. PMID: 26544362 French. No abstract available.
Les résultats de la néphrectomie partielle pour les carcinomes chromophobes du rein sont excellents. Étude rétrospective multicentrique à partir de 234 cas.
Bigot P, Bernhard J, Gill I, Vuong N, Verhoest G, Flammand V, Reix B, Suer E, Gökce I, Beauval J, Nouhaud F, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet J, Ploussard G, Roupret M, Léon P, El Bakri A, Larré S, Tillou X, Doerfler A, Descazeaud A. Bigot P, et al. Prog Urol. 2015 Nov;25(13):800. doi: 10.1016/j.purol.2015.08.168. Prog Urol. 2015. PMID: 26544363 French. No abstract available.
Cancer du rein cliniquement localisé : quels sont les facteurs prédictifs du risque d'upstaging pathologique pT3a par invasion de la graisse ?
Bernhard J, Patard J, Bigot P, Suer E, Vuong N, Verhoest G, Alimi Q, Flamand V, Reix B, Beauval J, Benoit T, Nouhaud F, Lenormand C, Hamidi N, Eto M, Larre S, El Bakri A, Baco E, Ploussard G, Koutlidis N, Schneider A, Roupret M, Leon P, Carrouget J, Droupy S, Marchal S. Bernhard J, et al. Prog Urol. 2015 Nov;25(13):800. doi: 10.1016/j.purol.2015.08.169. Prog Urol. 2015. PMID: 26544364 French. No abstract available.
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
Reix B, Bernhard JC, Patard JJ, Bigot P, Villers A, Suer E, Vuong NS, Verhoest G, Alimi Q, Beauval JB, Benoit T, Nouhaud FX, Lenormand C, Hamidi N, Cai J, Eto M, Larre S, El Bakhri A, Ploussard G, Hung A, Koutlidis N, Schneider A, Carrouget J, Droupy S, Marchal S, Doerfler A, Seddik S, Matsugasumi T, Orsoni X, Descazeaud A, Pfister C, Bensalah K, Soulie M, Gill I, Flamand V; Kidney Cancer group of the CCAFU. Reix B, et al. Among authors: vuong ns. Prog Urol. 2018 Mar;28(3):146-155. doi: 10.1016/j.purol.2017.12.004. Epub 2018 Jan 11. Prog Urol. 2018. PMID: 29331568 Free PMC article.
Robot-assisted versus open surgery for radical nephrectomy with level 1-2 vena cava tumor thrombectomy: a French monocenter experience (UroCCR study #73).
Vuong NS, Ferriere JM, Michiels C, Calen L, Tesi L, Capon G, Bensadoun H, Alezra E, Estrade V, Robert G, Bladou F, Bernhard JC. Vuong NS, et al. Minerva Urol Nephrol. 2021 Aug;73(4):498-508. doi: 10.23736/S2724-6051.20.04052-7. Epub 2020 Nov 17. Minerva Urol Nephrol. 2021. PMID: 33200900 Free article.
17 results